Alarm set off by French Nobel Laureate Luc Montaigner’s claim that the jabs could create virus variants. Antibody dependent enhancement (ADE), when antibodies to an infection can sometimes aggravate infection or trigger a respiratory disease, is something that vaccine developers must watch out for. However, there is no scientific case that such ADE may actually trigger newer virus variants, says experts. “All (Sars cov2) vaccines were being evaluated to see that they made high amounts of neutralising antibodies. But in an immune individual amongst a large number of antibodies, such ADE causing antibodies are pretty much impossible to identify.”

Source: The Hindu May 26, 2021 14:48 UTC